Lv41
440 积分 2024-12-10 加入
Anti-CD38 therapy for PLA2R-positive membranous nephropathy resistant to conventional immunosuppression
3小时前
已完结
Daratumumab for Anti-CD20-Refractory Membranous Nephropathy
3小时前
求助中
Daratumumab for multidrug-resistant phospholipase-A2 receptor–related membranous nephropathy
3小时前
已完结
Enhanced VLAD
20天前
已关闭
Nephrotic Syndrome in Rats Produced by Sensitization to Rat Kidney Proteins: Immunologic Studies
20天前
已完结
High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy
1个月前
已完结
Risk Factors Associated with the Occurrence of Anti-rituximab Antibodies in Membranous Nephropathy
1个月前
已完结
Novel approaches to primary membranous nephropathy: Beyond the KDIGO guidelines
2个月前
已完结
Daratumumab for Anti-CD20-Refractory Membranous Nephropathy
2个月前
已关闭
Belimumab and Rituximab for the Treatment of Primary Membranous Nephropathy: Initial REBOOT Results
2个月前
已关闭
皖公网安备34019202002308
